COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 459: Articles 4581-4590  | Next

HPV and HBV vaccine hesitancy, intention and uptake in the era of social media and COVID-19: A review
Vraga, E. K., Brady, S. S., Gansen, C., Khan, E. M., Bennis, S. L., Nones, M., Tang, R., Srivastava, J., Kulasingam, S.
10.1101/2023.01.25.23285015 — Posted: 2023-01-26
Estimations of SARS-CoV-2 endemic characteristics
Nesteruk, I.
10.1101/2023.01.24.23284980 — Posted: 2023-01-26
Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children
Avramescu, M., Isnard, P., Temmam, S., Chevalier, A., Bastard, P., Attia, M., Berthaud, R., Fila, M., Dossier, C., Hogan, J., Ulinski, T., Leguevaques, D., Louillet, F., Martinez Casado, E., Halimi, J.-M., Cloarec, S., Zaloszyc, A., Faudeux, C., Rousset-Rouviere, C., Clave, S., Harambat, J., Rollot, E., Simon, T., Nallet-Amate, M., Ranchin, B., Bacchetta, J., Porcheret, F., Bernard, J., Ryckewaert, A., Jamet, A., Fourgeaud, J., Da Rocha, N., Perot, P., Kuperwasser, N., Bouazza, N., Rabant, M., Duong Van Huyen, J.-P., P Robert, M., Zuber, J., Casanova, J.-L., eloit, m., Sermet-Gaudelus, I., Boyer, O.
10.1101/2023.01.23.23284848 — Posted: 2023-01-26
Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study
Evans, A., Qi, C., Adebayo, L., Underwood, J., Coulson, J., Bailey, R., John, G., Cooper, A., Akbari, A., Lyons, R., Edwards, A.
10.1101/2023.01.24.23284916 — Posted: 2023-01-25
The impact of COVID-19 lockdown on a cohort of adults with recurrent major depressive disorder from Catalonia: a decentralized longitudinal study using remote measurement technology
Lavalle, R., Condominas, E., Haro, J. M., Gine-Vazquez, I., Bailon, R., Laporta, E., Garcia, E., Kontaxis, S., Riquelme, G., Lombardini, F., Preti, A., Penarrubia Maria, M. T., Coromina, M., Arranz, B., Vilella, E., Rubio Abadal, E., Matcham, F., Lamers, F., Hotopf, M., Penninx, B. W. J. H., Annas, P., Narayan, V., Simblett, S. K., Siddi, S.
10.1101/2023.01.24.23284906 — Posted: 2023-01-25
A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection
Farkas, D., Bogamuwa, S., Piper, B., Newcomb, G., Gunturu, P., Bednash, J. S., Londino, J. D., Elhance, A., Nho, R., Rosas Mejia, O., Yount, J. S., Horowitz, J. C., Goncharova, E. A., Mallampalli, R. K., Robinson, R. T., Farkas, L.
10.1101/2023.01.25.524586 — Posted: 2023-01-25
Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
Mitsi, E., Diniz, M. O., Reine, J., Collins, A. M., Robinson, R., Hyder-Wright, A., Farrar, M., Liatsikos, K., Hamilton, J., Onyema, O., Urban, B. C., Solorzano, C., Lambe, T., Draper, S. J., Weiskopf, D., Sette, A., Maini, M. K., Ferreira, D. M.
10.1101/2023.01.25.525485 — Posted: 2023-01-25
COVID-19 in Pakistan: A national analysis of five pandemic waves
Ahmad, T., Abdullah, M., Mueed, A., Sultan, F., Khan, A., Khan, A. A.
10.1101/2023.01.23.23284902 — Posted: 2023-01-25
RAMEN identifies effective indicators for severe COVID and Long COVID patients
Xiong, Y., Wang, J., Shang, X., Chen, T., Fonseca, G., Rousseau, S., Ding, J.
10.1101/2023.01.24.525413 — Posted: 2023-01-25
Second monovalent SARS-CoV-2 mRNA booster restores Omicron-specific neutralizing activity in both nursing home residents and health care workers
Nugent, C., Abul, Y., White, E., Shehadeh, F., Kaczynski, M., Felix, L. O., Ganesan, N., Oyebanji, O. A., Vishnepolskiy, I., Didion, E. M., Paxitzis, A., Sheehan, M. L., Mylonakis, E., Wilson, B. M., Balazs, A. B., Chan, P. A., King, C. L., Pfeifer, W. M., Dickerson, E., Canaday, D. H., Gravenstein, S.
10.1101/2023.01.22.23284881 — Posted: 2023-01-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).